Drug recall · February 7, 2024
Budesonide Extended-Release Tablets recall
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPC 5140782430, NDC 51407-824-30
- Lots / codes
Lot #: GS054862, Exp. Date 07/31/2025
- Quantity
- 108 bottles
- Company
- Golden State Medical Supply Inc., Camarillo, CA
- Distribution
- Illinois only
- Initiated
- January 12, 2024 · Voluntary: Firm initiated
- Classified
- January 29, 2024
- Reported
- February 7, 2024
- Ended
- March 20, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Budesonide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.